GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Level Biotechnology Inc (ROCO:3118) » Definitions » Cyclically Adjusted PB Ratio

Level Biotechnology (ROCO:3118) Cyclically Adjusted PB Ratio : 1.75 (As of May. 29, 2025)


View and export this data going back to 2008. Start your Free Trial

What is Level Biotechnology Cyclically Adjusted PB Ratio?

As of today (2025-05-29), Level Biotechnology's current share price is NT$33.55. Level Biotechnology's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was NT$19.20. Level Biotechnology's Cyclically Adjusted PB Ratio for today is 1.75.

The historical rank and industry rank for Level Biotechnology's Cyclically Adjusted PB Ratio or its related term are showing as below:

ROCO:3118' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.33   Med: 1.69   Max: 2.31
Current: 1.73

During the past years, Level Biotechnology's highest Cyclically Adjusted PB Ratio was 2.31. The lowest was 1.33. And the median was 1.69.

ROCO:3118's Cyclically Adjusted PB Ratio is ranked worse than
54.18% of 670 companies
in the Biotechnology industry
Industry Median: 1.485 vs ROCO:3118: 1.73

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Level Biotechnology's adjusted book value per share data for the three months ended in Mar. 2025 was NT$17.865. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$19.20 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Level Biotechnology Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Level Biotechnology's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Biotechnology Cyclically Adjusted PB Ratio Chart

Level Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.81 1.71 1.50 1.62 1.68

Level Biotechnology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 1.87 1.71 1.68 1.73

Competitive Comparison of Level Biotechnology's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Level Biotechnology's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Biotechnology's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Level Biotechnology's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Level Biotechnology's Cyclically Adjusted PB Ratio falls into.


;
;

Level Biotechnology Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Level Biotechnology's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=33.55/19.20
=1.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Level Biotechnology's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Level Biotechnology's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=17.865/134.9266*134.9266
=17.865

Current CPI (Mar. 2025) = 134.9266.

Level Biotechnology Quarterly Data

Book Value per Share CPI Adj_Book
201506 14.834 100.684 19.879
201509 15.451 100.392 20.766
201512 16.166 99.792 21.858
201603 16.636 100.470 22.341
201606 14.813 101.688 19.655
201609 15.157 101.861 20.077
201612 15.883 101.863 21.039
201703 16.423 102.862 21.542
201706 15.183 103.349 19.822
201709 15.452 104.136 20.021
201712 16.093 104.011 20.876
201803 16.273 105.290 20.854
201806 14.688 106.317 18.641
201809 14.986 106.507 18.985
201812 15.369 105.998 19.563
201903 15.609 107.251 19.637
201906 15.051 108.070 18.791
201909 15.413 108.329 19.197
201912 15.831 108.420 19.701
202003 16.072 108.902 19.913
202006 15.221 108.767 18.882
202009 15.663 109.815 19.245
202012 16.314 109.897 20.030
202103 16.880 111.754 20.380
202106 17.362 114.631 20.436
202109 16.331 115.734 19.039
202112 16.789 117.630 19.258
202203 17.127 121.301 19.051
202206 15.746 125.017 16.994
202209 16.158 125.227 17.410
202212 16.713 125.222 18.008
202303 17.219 127.348 18.244
202306 15.981 128.729 16.750
202309 16.333 129.860 16.970
202312 16.931 129.419 17.651
202403 17.522 131.776 17.941
202406 16.168 132.554 16.457
202409 16.629 133.029 16.866
202412 17.253 133.157 17.482
202503 17.865 134.927 17.865

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Level Biotechnology  (ROCO:3118) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Level Biotechnology Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Level Biotechnology's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
No. 80, Lane 169, Kangning Street, Xizhi District, New Taipei City, TWN, 221
Level Biotechnology Inc is a Taiwan-based company engaged in the sales of biomedical products and providing preclinical testing services. The company's service area includes Mammalian Toxicology, Genetic Toxicology, Pharmacology, Biocompatibility, and Model Animal Production.

Level Biotechnology Headlines

No Headlines